{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:22:55Z","timestamp":1784262175637,"version":"3.55.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Left bundle branch (LBB) pacing could achieve cardiac resynchronization therapy (CRT) in patients who cannot be resynchronized via the placement of the left ventricle (LV) lead into the coronary sinus. LBB pacing could improve cardiovascular outcomes in heart failure (HF) patients with LBB block who are affected by type 2 diabetes mellitus (T2DM).<\/jats:p><\/jats:sec><jats:sec><jats:title>Study hypothesis<\/jats:title><jats:p>LBB pacing could increase the number of CRT responders and lead to the best clinical outcomes in HF patients with T2DM, inducing cardiac remodeling and improving left ventricle ejection fraction (LVEF) via microRNA (miR) modulation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In a multicenter observational study, we enrolled 334 HF patients with LBB block and an indication to receive LBB pacing for CRT. In these patients, we evaluated the CRT responder rate, clinical outcomes, and miR expression at 1 year of follow-up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At 1 year of follow-up, we had 223 responders (66.8%), 132 hospitalizations for HF (39.5%), 24 cardiac deaths (7.2%), and 37 all-cause deaths (11.1%), with a higher rate of HF hospitalizations (77 (69.4%) vs 55 (24.7%), <jats:italic>p<\/jats:italic> &amp;lt; 0.05), and cardiac deaths (13 (11.7% vs 11 (4.9%), <jats:italic>p<\/jats:italic> &amp;lt; 0.05) in non-responders vs responders. At the end of follow-up, we found the lowest expression of miR-26, miR-29, miR-30, miR-92, and miR-145 in LBB-pacing non-responders vs responders (<jats:italic>p<\/jats:italic> &amp;lt; 0.05), and a direct correlation between miR-30 (0.340, [0.833\u20131.915]; p 0.001), the 6-minute-walking test (6MWT; 0.168, [0.008\u20130.060]; p 0.011), angiotensin-receptor-neprilysin inhibitors (ARNI; 0.157, [0.183\u20134.877]; p 0.035), sodium-glucose-transporter-2 inhibitors (0.245, [2.242\u20137.283]; p 0.001), and LVEF improvements. C reactive protein (CRP) inversely correlated with LVEF improvement (\u22120.220, [-(0.066\u20130.263)]; p 0.001). ARNI (1.373, CI 95% [1.007\u20131.872], p 0.045), miR-30 (2.713, CI 95% [1.543\u20134.769], p 0.001), and 6MWT (1.288, CI 95% [1.084\u20131.998], p 0.001) were predictors of LBB pacing responders at 1 year of follow-up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>LBB-pacing responders evidenced miR modulation, which was linked to significant improvement of the cardiac pump. Specifically, miR-30 was linked to cardiac pump improvement and predicted responders at 1 year of follow-up in patients with T2DM.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1402782","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T04:58:51Z","timestamp":1716267531000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes"],"prefix":"10.3389","volume":"15","author":[{"given":"Celestino","family":"Sardu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Vittoria Marfella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina Claudia","family":"Lepre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanbattista","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Volpicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Contaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Galiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Caturano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Casolaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando Carlo","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Uran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Signoriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Paolisso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Marfella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","article-title":"Reappraising the role of inflammation in heart failure","volume":"17","author":"Adamo","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3390\/biomedicines11041037","article-title":"Impact of sacubitril\/valsartan on circulating microRNA in patients with heart failure","volume":"11","author":"Brioschi","year":"2023","journal-title":"Biomedicines"},{"key":"B3","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/europace\/euab249","article-title":"Cardiac resynchronization therapy via left bundle branch pacing vs. optimized biventricular pacing with adaptive algorithm in heart failure with left bundle branch block: a prospective, multi-centre, observational study","volume":"24","author":"Chen","year":"2022","journal-title":"Europace"},{"key":"B4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/s0735-1097(99)00630-0","article-title":"Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","article-title":"Chronic heart failure and inflammation: what do we really know?","volume":"119","author":"Dick","year":"2016","journal-title":"Circ. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"101337","DOI":"10.1016\/j.molmet.2021.101337","article-title":"Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of sodium-glucose co-transporter2 inhibitor treatment","volume":"54","author":"D'Onofrio","year":"2021","journal-title":"Mol. Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.healun.2021.12.008","article-title":"Glycation of ryanodine receptor in circulating lymphocytes predicts the response to cardiac resynchronization therapy","volume":"41","author":"Gambardella","year":"2022","journal-title":"J. Heart Lung Transpl."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur. Heart J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.echo.2008.01.003","article-title":"Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting\u2014a report from the American society of echocardiography dyssynchrony writing group endorsed by the heart rhythm society","volume":"21","author":"Gorcsan","year":"2008","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e14506","DOI":"10.1371\/journal.pone.0014506","article-title":"Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin","volume":"6","author":"Jankowska","year":"2011","journal-title":"PLoS ONE"},{"key":"B11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/sji.12328","article-title":"Effect of cardiac resynchronization therapy on inflammation in congestive heart failure: a review","volume":"82","author":"Lappeg\u00e5rd","year":"2015","journal-title":"Scand. J. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1124613","DOI":"10.3389\/fendo.2023.1124613","article-title":"Diabetic cardiomyopathy: the role of microRNAs and long non-coding RNAs","volume":"14","author":"Macvanin","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e24380","DOI":"10.1002\/jcla.24380","article-title":"Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients","volume":"36","author":"Mahjoob","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1093\/eurjhf\/hft088","article-title":"Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders","volume":"15","author":"Marfella","year":"2013","journal-title":"Eur. J. Heart Fail"},{"key":"B15","doi-asserted-by":"publisher","first-page":"154936","DOI":"10.1016\/j.metabol.2021.154936","article-title":"Sodium\/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts","volume":"127","author":"Marfella","year":"","journal-title":"Metabolism"},{"key":"B16","doi-asserted-by":"publisher","first-page":"106448","DOI":"10.1016\/j.phrs.2022.106448","article-title":"Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes","volume":"184","author":"Marfella","year":"","journal-title":"Pharmacol. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.114.013220","article-title":"Circulating MicroRNA-30d is associated with response to cardiac resynchronization therapy in heart failure and regulates cardiomyocyte apoptosis: a translational pilot study","volume":"131","author":"Melman","year":"2015","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.2337\/dc09-9029","article-title":"American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control","volume":"32","author":"Ref Moghissi","year":"2009","journal-title":"Diabetes Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7292564","DOI":"10.1155\/2016\/7292564","article-title":"Cardiac resynchronization therapy outcomes in type 2 diabetic patients: role of MicroRNA changes","volume":"2016","author":"Sardu","year":"2016","journal-title":"J. Diabetes Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3389\/fphys.2018.00758","article-title":"Stretch, injury and inflammation markers evaluation to predict clinical outcomes after implantable cardioverter defibrillator therapy in heart failure patients with metabolic syndrome","volume":"9","author":"Sardu","year":"","journal-title":"Front. Physiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s12265-014-9545-9","article-title":"Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people","volume":"7","author":"Sardu","year":"2014","journal-title":"J. Cardiovasc Transl. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"106303","DOI":"10.1016\/j.phrs.2022.106303","article-title":"Angiotensin receptor\/Neprilysin inhibitor effects in CRTd non-responders: from epigenetic to clinical beside","volume":"182","author":"Sardu","year":"2022","journal-title":"Pharmacol. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12933-018-0778-9","article-title":"Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate","volume":"17","author":"Sardu","year":"","journal-title":"Cardiovasc. Diabetol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12933-023-01814-7","article-title":"SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosis","volume":"22","author":"Sardu","year":"2023","journal-title":"Cardiovasc Diabetol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jacep.2020.08.015","article-title":"Left bundle branch area pacing for cardiac resynchronization therapy: results from the international LBBAP collaborative study group","volume":"7","author":"Vijayaraman","year":"2021","journal-title":"JACC Clin. Electrophysiol."},{"key":"B26","first-page":"138","article-title":"Extracellular\/circulating microRNAs and their potential role in cardiovascular disease","volume":"1","author":"Zhu","year":"2011","journal-title":"Am. J. Cardiovasc Dis."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1402782\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T04:58:54Z","timestamp":1716267534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1402782\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":26,"alternative-id":["10.3389\/fphar.2024.1402782"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1402782","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,21]]},"article-number":"1402782"}}